A detailed history of Flputnam Investment Management CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Flputnam Investment Management CO holds 6,592 shares of NVO stock, worth $579,898. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,592
Previous 5,201 26.74%
Holding current value
$579,898
Previous $742,000 5.66%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$119.07 - $145.42 $165,626 - $202,279
1,391 Added 26.74%
6,592 $784,000
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $34,726 - $41,575
283 Added 5.75%
5,201 $742,000
Q1 2024

May 03, 2024

BUY
$102.11 - $135.92 $816 - $1,087
8 Added 0.16%
4,918 $631,000
Q4 2023

Jan 30, 2024

SELL
$87.78 - $105.45 $20,628 - $24,780
-235 Reduced 4.57%
4,910 $507,000
Q3 2023

Nov 06, 2023

BUY
$90.94 - $199.54 $233,988 - $513,416
2,573 Added 100.04%
5,145 $467,000
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $32,287 - $35,738
207 Added 8.75%
2,572 $416,000
Q1 2023

Apr 27, 2023

BUY
$132.34 - $159.14 $45,127 - $54,266
341 Added 16.85%
2,365 $376,000
Q4 2022

Jan 31, 2023

BUY
$102.55 - $135.33 $207,561 - $273,907
2,024 New
2,024 $273,000
Q2 2022

Aug 08, 2022

SELL
$103.24 - $121.81 $208,441 - $245,934
-2,019 Closed
0 $0
Q1 2022

Apr 28, 2022

SELL
$93.1 - $112.54 $71,407 - $86,318
-767 Reduced 27.53%
2,019 $224,000
Q3 2021

Oct 26, 2021

SELL
$84.42 - $106.62 $5,487 - $6,930
-65 Reduced 2.28%
2,786 $267,000
Q2 2021

Aug 11, 2021

BUY
$67.66 - $84.76 $192,898 - $241,650
2,851 New
2,851 $239,000
Q4 2020

Feb 02, 2021

SELL
$63.89 - $73.8 $187,133 - $216,160
-2,929 Closed
0 $0
Q3 2020

Nov 03, 2020

BUY
$63.69 - $70.22 $186,548 - $205,674
2,929 New
2,929 $203,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $199B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Flputnam Investment Management CO Portfolio

Follow Flputnam Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flputnam Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Flputnam Investment Management CO with notifications on news.